Overview
VISEN PHARMA-B (2561)
VISEN Pharmaceuticals, an investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese M...
- Open
- 12.700
- High
- 12.700
- Low
- 11.510
- Prev. Close
- 12.460
- Volume
- 16.50K
- Turnover
- 199.86K
- Avg Price
- 12.113
- Bid/Ask Ratio
- -9.09%
- Amplitude
- 9.55%
- 52wk High
- 43.300
- Volume Ratio
- 1.72
- Turnover Ratio
- 0.01%
- 52wk Low
- 10.900
- HK Mkt Cap
- 1.43B
- Market CapHKD
- 1.43B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.42
- EPSDynamic
- -2.11
- EPSStatic
- --
- BVPS
- 6.79
- P/B
- 1.85
- HK Shares
- 113.75M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 113.75M
- Min lot size
- 100
- Currency
- HKD
VISEN PHARMA-B Analyst Rating
View moreForecast & Rating
Sep 4, 2026- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
Visen Pharmaceuticals staged a morning-session rally before paring gains, touching an intraday high of HKD 26.96 and closing at HKD 26.42, up 5.68% from the previous close of HKD 25.00. The move was driven by multiple recent governance and commercial developments: the appointment of three new non-executive directors and continued share buyback and cancellation activities, signaling management's focus on value creation. While Q4 2025 net loss widened to HKD 75.3 million, the year-on-year loss contraction of 34.16% and an 88.32% improvement in EPS provided investors with marginal profit recovery signals. The stock remains 50.06% below its 52-week high of HKD 52.90 and beneath the MA60 of HKD 23.31, though it has reclaimed the MA20 (HKD 20.55) and rebounded roughly 40% from its 52-week low of HKD 18.88. However, the company is still in the pre-commercialization stage with persistent negative operating margins, and a fundamental turnaround in profitability remains unproven.
News
Market Movers · Visen Pharma falls 8% in Hong Kong trading
Weekly Review · Weekly Recap | VISEN PHARMA-B +0.48%, wild swings but weekly gain
Market Movers · VISEN PHARMA falls 10% in Hong Kong trading
Market Movers · 维昇药业-B 跌约 6%。
Market Movers · VISEN PHARMA-B rose approximately 7%
Market Movers · VISEN PHARMA drops 7% in Hong Kong trading
